The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/3D82FD3D.svg?ark=w1%2F20260515%2F3D82FD3D&value=id)](https://nobleid.org/work/w1/20260515/3D82FD3D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors